In the context of the experimental glioblastoma microenvironment, miR-1 directly targets annexin A2 and the proto-oncogene MET, and miR-1-loaded extracellular vesicles lead to diminished invasion and proliferation in targeted cells (82). The gene discussed is MET; the disease is glioblastoma.